产品资料

2T8-3E10细胞

如果您对该产品感兴趣的话,可以
产品名称: 2T8-3E10细胞
产品型号: 2T8-3E10
产品展商: HZbscience
产品文档: 无相关文档

简单介绍

2T8-3E10细胞应如何避免细胞污染,细胞污染的种类可分成**、酵母菌、霉菌、病毒和霉浆菌。主要的污染原因为无菌操作技术不当、操作室环境不佳、污染之血清和污染之细胞等。严格之无菌操作技术、清洁的环境、与品质良好之细胞来源和培养基配制是减低污染之*好方法。2T8-3E10细胞何时须更换培养基?视细胞生长密度而定,或遵照细胞株基本数据上之更换时间,按时更换培养基即可。


2T8-3E10细胞  的详细介绍

2T8-3E10细胞

ATCC Number: HB-8213™

生长状态: 悬浮生长

运输方式: 冻存运输

是否是肿瘤细胞: 0

物种来源: 小鼠

数量: 大量

细胞形态: **样

**类型: IgM

Designations: 2T8-3E10

2T8-3E10细胞Depositors: Dana Farber Cancer Inst.

Isotype: IgM

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

Growth Properties: suspension

Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)

Morphology: lymphoblast


Source: Cell Type: hybridoma: B lymphocyte;

Cellular Products: 2T8-3E10细胞immunoglobulin; monoclonal antibody; against human T cell antigen (Ti1b antigen) expressed only on the CT8III cytotoxic T lymphocyte clone

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Tumorigenic: Yes

Comments: Animals were immunized with CT8III cells.

Spleen cells were fused with NS-1 myeloma cells.

The antibody does not react with human thymocytes or resting or activated peripheral T cells.

Propagation: 2T8-3E10细胞ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 64%; NCTC 109 medium, 10%; L-glutamine, 2%; sodium pyruvate, 1%; hypoxanthine-thymidine, 1%; oxaloacetic acid and insulin, 1%; horse serum, 10%; fetal bovine serum, 10%

Subculturing: Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.

References: 3546: Schlossman SF, et al. 2T8-3E10细胞Monoclonal antibodies that recognize human T cells. US Patent 4,550,086 dated Oct 29 1985

沪公网安备 31011702004356号